Furthermore, while plasma NfL is the most published blood biomarker related to AD, it was also not considered due to its global association to neurodegeneration [26, 27] and neurological injury [28, 116] (e.g. nonspecificity for AD). Here, NEFL is linked to Alzheimer disease.